International Journal of Molecular Sciences, Journal Year: 2024, Volume and Issue: 25(21), P. 11451 - 11451
Published: Oct. 25, 2024
Sarcopenia is a systemic medical disorder characterized by gradual decline in muscular strength, function, and skeletal muscle mass. Currently, there no medication specifically approved for the treatment of this condition. Therefore, identification new pharmacological targets may offer opportunities development novel therapeutic strategies. The current silico study investigated active ingredients mode action
Language: Английский